Fragoso-Ontiveros, V.; De la Fuente-Hernandez, M.A.; Gonzalez-Osnaya, V.; Gamez-Rosales, M.; Perez-Montiel, M.D.; Isla-Ortiz, D.; Cantu-De Leon, D.F.; Alvarez-Gomez, R.M.
A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer. Int. J. Mol. Sci. 2023, 24, 1398.
https://doi.org/10.3390/ijms24021398
AMA Style
Fragoso-Ontiveros V, De la Fuente-Hernandez MA, Gonzalez-Osnaya V, Gamez-Rosales M, Perez-Montiel MD, Isla-Ortiz D, Cantu-De Leon DF, Alvarez-Gomez RM.
A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer. International Journal of Molecular Sciences. 2023; 24(2):1398.
https://doi.org/10.3390/ijms24021398
Chicago/Turabian Style
Fragoso-Ontiveros, Veronica, Marcela Angelica De la Fuente-Hernandez, Vincent Gonzalez-Osnaya, Mario Gamez-Rosales, Maria Delia Perez-Montiel, David Isla-Ortiz, David Francisco Cantu-De Leon, and Rosa Maria Alvarez-Gomez.
2023. "A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer" International Journal of Molecular Sciences 24, no. 2: 1398.
https://doi.org/10.3390/ijms24021398
APA Style
Fragoso-Ontiveros, V., De la Fuente-Hernandez, M. A., Gonzalez-Osnaya, V., Gamez-Rosales, M., Perez-Montiel, M. D., Isla-Ortiz, D., Cantu-De Leon, D. F., & Alvarez-Gomez, R. M.
(2023). A Pathogenic Variant Reclassified to the Pseudogene PMS2P1 in a Patient with Suspected Hereditary Cancer. International Journal of Molecular Sciences, 24(2), 1398.
https://doi.org/10.3390/ijms24021398